Showing results (2161-2170 of 3,662) with videos related to
Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|September 25, 2024
AI-based strategies in breast mass ≤ 2 cm classification with mammography and tomosynthesisZhenzhen Shao, Yuxin Cai, Yujuan Hao, et al.Breast (Edinburgh, Scotland)|October 2, 2024
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancerShuqin Dai, Xingping Wu, Xuefang Huang, et al.Breast (Edinburgh, Scotland)|September 13, 2024
Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysisJannah Baker, Naomi Noguchi, M Luke Marinovich, et al.Breast (Edinburgh, Scotland)|September 20, 2024
Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelinesDavid Groheux, Sofia C Vaz, Philip Poortmans, et al.Breast (Edinburgh, Scotland)|October 17, 2024
Multimodal ultrasound assessment of mass and non-mass enhancements by MRI: Diagnostic accuracy in idiopathic granulomatous mastitis and breast cancerLiang Yin, Xi Wei, Qing Zhang, et al.Breast (Edinburgh, Scotland)|November 7, 2024
Adjuvant denosumab for early breast cancer-Evidence and controversyLaura Moretti, Laura Richelmi, Deborah Cosentini, et al.Breast (Edinburgh, Scotland)|October 23, 2024
Radiotherapy and increased risk of second primary cancers in breast cancer survivors: An epidemiological and large cohort studyNiuniu Hou, Zhe Wang, Yuwei Ling, et al.Breast (Edinburgh, Scotland)|February 13, 2025
Experiences and preferences about information on treatment-related side effects among patients with early breast cancerAntonio Di Meglio, Giuseppe Catanuto, Marzia Zambon, et al.Breast (Edinburgh, Scotland)|February 13, 2025
An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42Vesna Bjelic-Radisic, Fatima Cardoso, Joachim Weis, et al.Breast (Edinburgh, Scotland)|February 15, 2025
Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trialBinghe Xu, Qingyuan Zhang, Tao Sun, et al.Pageof 367